Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose dose escalation study of glycopyrrolate inhalation solution in COPD
2009-010821-38Phase 2Completed
- Sponsor
- Elevation Pharmaceuticals
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of glycopyrronium in chronic obstructive pulmonary disease (COPD), sponsored by Elevation Pharmaceuticals. Primary endpoints: Safety and tolerability of single-dose glycopyrrolate inhalation solution, Pharmacokinetics of glycopyrrolate inhalation solution and 1 more. Started Apr 2009; status: completed.
02
Drugs
glycopyrronium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on 2009-010821-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010821-38.